Concepedia

Publication | Open Access

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

DOIFull Paper Access

90

Citations

37

References

2019

Year

Jun‐Hai Tang, Lin Yang, Juxiang Chen, Qingrui Li, Lirong Zhu, Qingfu Xu, Guo‐Hao Huang, Zuo‐Xin Zhang, Xiang Yan, Lei Du,
Cancer Communications

Abstract

Bortezomib was found to inhibit glioma growth and improved TMZ chemotherapy efficacy, probably via down-regulating the FOXM1-Survivin axis. Bortezomib might be a promising agent for treating malignant glioma, alone or in combination with TMZ.

References

YearCitations

Page 1